ArriVent BioPharma, Inc. (AVBP)
NASDAQ·Healthcare·Biotechnology
$13.81
+12.92%
Mkt Cap $658.26M
Analyst Ratings
Buy
15
Hold
0
Sell
0
Price Target (14 analysts)
$22.00
Range $18.00 – $29.00
Implied Upside
+59.3%
Consensus $22.00 vs current $13.81
NASDAQ·Healthcare·Biotechnology
$13.81
+12.92%
Mkt Cap $658.26M
Buy
15
Hold
0
Sell
0
Price Target (14 analysts)
$22.00
Range $18.00 – $29.00
+59.3%
Consensus $22.00 vs current $13.81